Dr. Charles S. Hesdorffer, MD

  • Bethesda, MD
  • Hematologist and oncologist
NPI1356302095
Part D claims, 2024
97
Publications
68
Clinical trials
7
Insurance carriers
1
State licenses
4
Practice address
10 Center Dr Rm 4-5140, Bethesda, MD 20892-0004
Practice phone
Call (310) 402-2339
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Hesdorffer's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Charles S. Hesdorffer is a hematologist and oncologist in Bethesda, Maryland

Dr. Hesdorffer practices in Bethesda, Maryland.

Dr. Hesdorffer's NPI, 1356302095, was assigned on March 31, 2006. Dr. Hesdorffer graduated from University of the Witwatersrand in 1978. Dr. Hesdorffer holds District of Columbia license MD040886.

NPI and contact details
NPI enumeration date
March 31, 2006
NPI status
Active
Practice phone
(310) 402-2339
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Medical school graduation
1978

Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data

Dr. Charles S. Hesdorffer's practice address is in Bethesda, Maryland

Dr. Hesdorffer's practice address in the NPI Registry is 10 Center Dr Rm 4-5140, Bethesda, MD 20892-0004. The practice phone is (310) 402-2339.

  • NPI Registry address
    10 Center Dr Rm 4-5140, Bethesda, MD 20892-0004Phone(310) 402-2339

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dmand AI tracks the EHR system at Dr. Charles S. Hesdorffer's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hesdorffer practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dr. Hesdorffer's practiceAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Hesdorffer practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Charles S. Hesdorffer is one of 245 hematologists and oncologists in Maryland

Hematology and oncology is Dr. Hesdorffer's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Hesdorffer's licenses on file in 4 states: District of Columbia, New York, Maryland and New Jersey.

Specialties and state licenses

  • Hematology and oncology, District of ColumbiaPrimaryLicense MD040886 · 2012 to 2027 · taxonomy 207RH0003X
  • New York licenseLicense 169687 · 1987 to 2025
  • Maryland license2006 to 2016
  • New Jersey license2005 to 2007

Hematologists and oncologists near Dr. Hesdorffer

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Charles S. Hesdorffer wrote 97 Medicare Part D claims in 2024

In 2024, Dr. Hesdorffer wrote 97 Medicare Part D claims. 89% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $192 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

Part D claims, 202497
Drugs named by CMS1
Total drug cost$192

Dr. Hesdorffer's Part D claims by kind of drug, 2024

  • Generic86 claims89%
  • Brand-name11 claims11%

Dr. Hesdorffer's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 142024: 1214%

Drugs named by CMS: 1 in 2024, 1 in 2023.

See all prescribing by Dr. Hesdorffer

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Hesdorffer by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Charles S. Hesdorffer has 68 publications on record

Dmand AI links 68 papers to Dr. Hesdorffer, published from 2006 to 2020. 2011 was the busiest year, with 3. The most frequent topics are Hematopoietic Stem Cell Transplantation, Antineoplastic Combined Chemotherapy Protocols and Breast Neoplasms. Dr. Hesdorffer has published most often in Blood. Dr. Hesdorffer's most frequent co-authors are William B. Ershler, MD, Luigi Ferrucci, MD and Dan L. Longo, MD.

Papers68
Years published2006 to 2020

Dr. Hesdorffer's papers by year, 2006 to 2020

Topics Dr. Hesdorffer writes about most

  • Hematopoietic Stem Cell Transplantation
  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Antigens, Neoplasm
  • CD4-Positive T-Lymphocytes
  • Amino Acid Sequence
  • Cells, Cultured
  • Melanoma

Dr. Hesdorffer's most frequent co-authors

Recent publications by Dr. Hesdorffer

See all 68 publications and co-authors

See who Dr. Hesdorffer researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Hesdorffer works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Charles S. Hesdorffer has worked on 7 clinical trials

Dmand AI links Dr. Hesdorffer to 7 clinical trials, 5 of them phase 2 studies. Conditions studied include Immunoglobulin Light-chain Amyloidosis, Breast Neoplasms and Esthesioneuroblastoma, Olfactory. Herbert Irving Comprehensive Cancer Center sponsors the most, 6.

Clinical trials with Dr. Hesdorffer by phase

  1. NonePhase 1: no trials
  2. 5Phase 2: 5 trials
  3. 1Phase 3: 1 trial
  4. NonePhase 4: no trials

Conditions in Dr. Hesdorffer's trials

  • Immunoglobulin Light-chain Amyloidosis
  • Breast Neoplasms
  • Esthesioneuroblastoma, Olfactory
  • Familial ependymoma
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

Recent clinical trials with Dr. Hesdorffer

See all 7 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Charles S. Hesdorffer has 15 awards and honors on record

Dmand AI lists 15 awards for Dr. Hesdorffer, most recently Best Doctor (2010 to present) in 2012.

Awards and honors for Dr. Hesdorffer

  1. 2012
    • Best Doctor (2010 to present)
    • Best Doctors (2004 to present)
  2. 2011
    • Elected as a Fellow of the Royal Society of Medicine (FRSM)
  3. 2010
    • Dedication to Teaching and Patient Care Award
  4. 2009
    • Best Cancer Doctors in America
    • Best Doctors in America
See all 15 awards

Source: Dmand AI Professional Profile Data

Dr. Charles S. Hesdorffer graduated from University of the Witwatersrand

Dr. Hesdorffer graduated from University of the Witwatersrand in 1978. Dr. Hesdorffer is a member of ASCO.

  1. Medical schoolUniversity of the Witwatersrand

Source: Dmand AI Professional Profile Data

Dr. Charles S. Hesdorffer accepts plans from 1 insurance carrier

Dr. Hesdorffer is in network with 1 carrier, including Elevance. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.

  • Elevance

Plan types Dr. Hesdorffer accepts, by number of carriers

  1. EPO1
  2. HMO1
  3. Medicare1
  4. POS1
  5. PPO1

Source: Dmand AI Insurance Network Data

Sources for Dr. Charles S. Hesdorffer's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Charles S. Hesdorffer

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Charles S. Hesdorffer's NPI number?

Dr. Charles S. Hesdorffer's NPI number is 1356302095. It was assigned on March 31, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Charles S. Hesdorffer?

Dr. Charles S. Hesdorffer is a hematologist and oncologist in Bethesda, Maryland. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Charles S. Hesdorffer practice?

Dr. Hesdorffer practices at 10 Center Dr Rm 4-5140, Bethesda, MD 20892-0004.

What is Dr. Charles S. Hesdorffer's office phone number?

The practice phone on file for Dr. Hesdorffer is (310) 402-2339.

What is Dr. Charles S. Hesdorffer's medical license number?

Dr. Hesdorffer holds District of Columbia license MD040886, one of the licenses on file in 4 states.

Which states has Dr. Charles S. Hesdorffer been licensed in?

Dmand AI has state licenses on file for Dr. Hesdorffer in District of Columbia (2012 to 2027), New York (1987 to 2025), Maryland (2006 to 2016) and New Jersey (2005 to 2007).

Where did Dr. Charles S. Hesdorffer go to medical school?

Dr. Hesdorffer graduated from University of the Witwatersrand in 1978.

What drugs does Dr. Charles S. Hesdorffer prescribe most?

In 2024 Medicare Part D data, Dr. Hesdorffer's most prescribed drugs by claims were Metformin HCl.

How long has Dr. Charles S. Hesdorffer been practicing?

Dr. Hesdorffer graduated from medical school in 1978, 48 years ago.

Does Dr. Charles S. Hesdorffer do research?

Dmand AI links 68 publications to Dr. Hesdorffer, published from 2006 to 2020. Dr. Hesdorffer has worked on 7 clinical trials.

Who does Dr. Charles S. Hesdorffer publish with?

Dr. Hesdorffer's most frequent co-authors are William B. Ershler, MD (3 shared papers), Luigi Ferrucci, MD (3 shared papers) and Dan L. Longo, MD (3 shared papers).

What insurance does Dr. Charles S. Hesdorffer accept?

Dr. Hesdorffer is in network with 1 carrier, including Elevance. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Maryland by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)